24/7 Patient Assistance: 760-405-8205

Loren Mell, MD

Radiation Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma

  • Bio & Insurance Information

    Dr. Loren Mell is a board-certified radiation oncologist based in La Jolla, California. He is one of the reputable experts in his area and has been working in the medical field for about twenty years, treating various cases of lung cancer, laryngeal cancer, and different types of mesothelioma. Dr. Mell graduated from the University of Chicago Pritzker School of Medicine and then completed his internship at the Resurrection Medical Center and residency in residency in Radiology at the University of Chicago. He collaborates with multiple hospitals in his area including the UC San Diego Moores Cancer Center and VA San Diego Healthcare System. Furthermore, he has also authored multiple research papers.

  • Education & Training


    University of Chicago Pritzker School of Medicine

    Medical School


    Resurrection Medical Center



    University of Chicago


  • Board Certifications

    American Board of Radiology - Radiation Oncology

  • Hospital & Practice

    UC San Diego Moores Cancer Center

    Languages: English/Spanish

    (866) 773-2703

    3855 Health Sciences Dr

    La Jolla, California 92093

    Read More

    VA San Diego Healthcare System

    Languages: English/Spanish

    (858) 552-8585

    3350 La Jolla Village Dr

    San Diego, California 92161

    Read More
  • Publications & Memberships

    Dr. Loren Mell has contributed to 3 publications.

    Longitudinal Changes in Active Bone Marrow for Cervical Cancer Patients Treated With Concurrent Chemoradiation Therapy.

    Noticewala, S. S.,Li, N.,Williamson, C. W.,Hoh, C. K.,Shen, H.,McHale, M. T.,Saenz, C. C.,Einck, J.,Plaxe, S.,Vaida, F.,Yashar, C. M.,Mell, L. K.; Int. J. Radiat. Oncol. Biol. Phys.. 2017 Mar 01.

    See more >>

    Bone Marrow-sparing Intensity Modulated Radiation Therapy With Concurrent Cisplatin For Stage IB-IVA Cervical Cancer: An International Multicenter Phase II Clinical Trial (INTERTECC-2).

    Mell, L. K.,Sirák, I.,Wei, L.,Tarnawski, R.,Mahantshetty, U.,Yashar, C. M.,McHale, M. T.,Xu, R.,Honerkamp-Smith, G.,Carmona, R.,Wright, M.,Williamson, C. W.,Kasaová, L...; Int. J. Radiat. Oncol. Biol. Phys.. 2017 Jan 28.

    See more >>

    The Impact of Radiation Oncologists on the Early Adoption of Hypofractionated Radiation Therapy for Early-Stage Breast Cancer.

    Boero, I. J.,Gillespie, E. F.,Hou, J.,Paravati, A. J.,Kim, E.,Einck, J. P.,Yashar, C.,Mell, L. K.,Murphy, J. D.; Int. J. Radiat. Oncol. Biol. Phys.. 2017 Jan 28.

    See more >>